Cargando…
Tetrastatin, the NC1 Domain of the α4(IV) Collagen Chain: A Novel Potent Anti-Tumor Matrikine
BACKGROUND: NC1 domains from α1, α2, α3 and α6(IV) collagen chains were shown to exert anti-tumor or anti-angiogenic activities, whereas the NC1 domain of the α4(IV) chain did not show such activities so far. METHODOLOGY/PRINCIPAL FINDINGS: We demonstrate in the present paper that the NC1 α4(IV) dom...
Autores principales: | Brassart-Pasco, Sylvie, Sénéchal, Karine, Thevenard, Jessica, Ramont, Laurent, Devy, Jérome, Di Stefano, Ludivine, Dupont-Deshorgue, Aurélie, Brézillon, Stéphane, Feru, Jezabel, Jazeron, Jean-François, Diebold, Marie-Danièle, Ricard-Blum, Sylvie, Maquart, François-Xavier, Monboisse, Jean Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335157/ https://www.ncbi.nlm.nih.gov/pubmed/22539938 http://dx.doi.org/10.1371/journal.pone.0029587 |
Ejemplares similares
-
Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the α4(IV) NC1 Domain of Collagen IV
por: Vautrin-Glabik, Alexia, et al.
Publicado: (2020) -
Conformation-dependent binding of a Tetrastatin peptide to α(v)β(3) integrin decreases melanoma progression through FAK/PI(3)K/Akt pathway inhibition
por: Lambert, Eléonore, et al.
Publicado: (2018) -
The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction
por: Oudart, Jean-Baptiste, et al.
Publicado: (2015) -
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX
por: Oudart, Jean-Baptiste, et al.
Publicado: (2015) -
Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA
por: Brassart, Bertrand, et al.
Publicado: (2019)